ClinicalTrials.govpublic full text
Screening and Genetic Monitoring of Patients With Myelodysplastic Syndromes (MDS) Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells
myelodysplastic syndromes (mds), chromosmal aberrations, karyotype evolution, rare abnormalities, cytogenetic monitoring, cytogenetics, fluorescence in situ hybridization (fish), cd34+ cells, peripheral blood, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 825076
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.